Loading...
Symbols:
Loading...
Symbols:
Exelixis Inc. (EXEL)
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on Exelixis Inc. (EXEL)
23 articles
Filter by:
Latest Articles Most commented on articlesMost frequent authors on EXEL
Most popular authors
(tracked in watchlists)
- Alan Brochstein(131)
- James Cullen(39)
- Ohad Hammer(38)
- Eben Tessari (21)
- Travis Johnson(13)
Most commented on authors
- Ohad Hammer(28)
- Alan Brochstein(11)
- Travis Johnson(3)
- Centient Biotech Investor(0)
- James Cullen(0)
- Bristol-Myers' Collaboration with Exelixis Is Looking Lucrative
- Buying More Exelixis in the Post - GlaxoSmithKline Era
- 'When There's Blood in the Streets', Buy Biotech Stocks
- Licensing Deal Is Imminent for ArQule
- Exelixis: A Platform Company for Oncology
- Poniard Pharmaceuticals: Platinum Rediscovered (Part II)
- Cancer Stocks: Tracking the Market
- Cancer Stocks: The Bleeding Slows
- Cancer Stocks Hammered Once Again
- Cancer Stocks Slide Again
- Cancer Stocks Plunge Following ASCO Meeting
- Four Cheap Biotech Stock Picks: Amgen, Aspreva, Exelixis, PDL Biopharma
- Four Conviction Buys for Our Age of Uncertainty
- Biotech In Review: Adams Respiratory Guides Lower
- Biotech Stocks Day In Review: Alfacell Receives Orphan Drug Status For Onconase
- Report From JPMorgan's HealthCare Conference: The Spinal Business Is Hot
- Biotech Stocks Day-in-Review: Amgen Strikes Drug Deal With Cytokinetics
- Exelixis' Special Purpose Entities A Far Cry From Enron (EXEL)
- Exelixis Upgraded With Good Reason (EXEL)
- Waiting For More Good News From Exelixis (EXEL)
-
Stocks Covered by The Biotech Stock Blog
on Oct 11, 2005
- How Exelixis Excels (EXEL)
- Exelixis Continues Its Wild Ride (EXEL)
Hedge Fund Jobs
Job Seekers: Search jobs by category, get job alerts by email or live feed, apply online See full list of jobs »
Employers: See all recruitment options, get applications online or by email Post a job »